Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Repetitive Transcranial Magnetic Seizure (rTMS) therapy as a tool to treat cognitive impairment in treatment-resistant depression
FY 2019-20
Summary
"Cognitive deficits are a common symptom in major depressive disorder, are associated with increased rates of disability, and are challenging to treat. Cognitive impairment is associated with poor treatment response, longer disease duration and poorer functioning. Thus, patients with treatment-resistant depression (TRD), whom do not respond to conventional treatments and experience disease chronicity, are at a higher risk for cognitive deficits. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive treatment modality that is effective in treatment-resistant depression. rTMS works by modulating the activity of a localized brain region in order to produce widespread functional changes. The prefrontal cortex is a brain area associated with complex cognitive functions and is also the brain target that rTMS stimulates to treat depression. Therefore, it has been hypothesized that rTMS might improve cognitive impairment in depression. The goal of the proposed master's project is to investigate whether an adequate course of rTMS in depression is associated with improvement of in cognitive symptoms in TRD patients. Cognitive assessments and fMRI brain scans were performed during baseline testing and 12 weeks post-treatment as part of a clinical trial examining differing rTMS treatment protocols in patients with TRD. Changes in cognition in patients will be compared to changes in cognition over the same time course in a sample of healthy volunteers in order to observe potential effects of treatment. If such effects exist, we will investigate the neurobiological underpinnings in the brain that are associated with improvements in cognition. "
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
428830
Name
Gregory Elizabeth C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Repetitive Transcranial Magnetic Seizure (rTMS) therapy as a tool to treat cognitive impairment in treatment-resistant depression
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cognitive Impairment; Functional Connectivity; Repetitive Transcranial Magnetic Stimulation; Treatment-Resistant Depression
Abstract
"Cognitive deficits are a common symptom in major depressive disorder, are associated with increased rates of disability, and are challenging to treat. Cognitive impairment is associated with poor treatment response, longer disease duration and poorer functioning. Thus, patients with treatment-resistant depression (TRD), whom do not respond to conventional treatments and experience disease chronicity, are at a higher risk for cognitive deficits. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive treatment modality that is effective in treatment-resistant depression. rTMS works by modulating the activity of a localized brain region in order to produce widespread functional changes. The prefrontal cortex is a brain area associated with complex cognitive functions and is also the brain target that rTMS stimulates to treat depression. Therefore, it has been hypothesized that rTMS might improve cognitive impairment in depression. The goal of the proposed master's project is to investigate whether an adequate course of rTMS in depression is associated with improvement of in cognitive symptoms in TRD patients. Cognitive assessments and fMRI brain scans were performed during baseline testing and 12 weeks post-treatment as part of a clinical trial examining differing rTMS treatment protocols in patients with TRD. Changes in cognition in patients will be compared to changes in cognition over the same time course in a sample of healthy volunteers in order to observe potential effects of treatment. If such effects exist, we will investigate the neurobiological underpinnings in the brain that are associated with improvements in cognition.   "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gregory, Elizabeth C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~